Identification and validation of ifit1 as an important innate immune bottleneck
PLoS ONE, ISSN: 1932-6203, Vol: 7, Issue: 6, Page: e36465
2012
- 29Citations
- 58Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations29
- Citation Indexes29
- 29
- CrossRef28
- Captures58
- Readers58
- 58
Article Description
The innate immune system plays important roles in a number of disparate processes. Foremost, innate immunity is a first responder to invasion by pathogens and triggers early defensive responses and recruits the adaptive immune system. The innate immune system also responds to endogenous damage signals that arise from tissue injury. Recently it has been found that innate immunity plays an important role in neuroprotection against ischemic stroke through the activation of the primary innate immune receptors, Toll-like receptors (TLRs). Using several large-scale transcriptomic data sets from mouse and mouse macrophage studies we identified targets predicted to be important in controlling innate immune processes initiated by TLR activation. Targets were identified as genes with high betweenness centrality, so-called bottlenecks, in networks inferred from statistical associations between gene expression patterns. A small set of putative bottlenecks were identified in each of the data sets investigated including interferon-stimulated genes (Ifit1, Ifi47, Tgtp and Oasl2) as well as genes uncharacterized in immune responses (Axud1 and Ppp1r15a). We further validated one of these targets, Ifit1, in mouse macrophages by showing that silencing it suppresses induction of predicted downstream genes by lipopolysaccharide (LPS)-mediated TLR4 activation through an unknown direct or indirect mechanism. Our study demonstrates the utility of network analysis for identification of interesting targets related to innate immune function, and highlights that Ifit1 can exert a positive regulatory effect on downstream genes. © 2012 McDermott et al.
Bibliographic Details
10.1371/journal.pone.0036465; 10.1371/journal.pone.0036465.t002; 10.1371/journal.pone.0036465.t001; 10.1371/journal.pone.0036465.g002; 10.1371/journal.pone.0036465.g001
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84862648393&origin=inward; http://dx.doi.org/10.1371/journal.pone.0036465; http://www.ncbi.nlm.nih.gov/pubmed/22745654; https://dx.plos.org/10.1371/journal.pone.0036465.t002; http://dx.doi.org/10.1371/journal.pone.0036465.t002; https://dx.plos.org/10.1371/journal.pone.0036465.t001; http://dx.doi.org/10.1371/journal.pone.0036465.t001; https://dx.plos.org/10.1371/journal.pone.0036465.g002; http://dx.doi.org/10.1371/journal.pone.0036465.g002; https://dx.plos.org/10.1371/journal.pone.0036465; https://dx.plos.org/10.1371/journal.pone.0036465.g001; http://dx.doi.org/10.1371/journal.pone.0036465.g001; https://dx.doi.org/10.1371/journal.pone.0036465.t002; https://journals.plos.org/plosone/article/figure?id=10.1371/journal.pone.0036465.t002; https://dx.doi.org/10.1371/journal.pone.0036465; https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0036465; https://dx.doi.org/10.1371/journal.pone.0036465.t001; https://journals.plos.org/plosone/article/figure?id=10.1371/journal.pone.0036465.t001; https://dx.doi.org/10.1371/journal.pone.0036465.g001; https://journals.plos.org/plosone/article/figure?id=10.1371/journal.pone.0036465.g001; https://dx.doi.org/10.1371/journal.pone.0036465.g002; https://journals.plos.org/plosone/article/figure?id=10.1371/journal.pone.0036465.g002; https://ohsu.pure.elsevier.com/en/publications/3734f50e-186f-4363-8a1e-b30f64f0a0bc; http://www.plosone.org/article/metrics/info:doi/10.1371/journal.pone.0036465; http://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0036465&type=printable; http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0036465; http://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0036465; https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0036465&type=printable; http://dx.plos.org/10.1371/journal.pone.0036465.t001; http://dx.plos.org/10.1371/journal.pone.0036465.g001; http://dx.plos.org/10.1371/journal.pone.0036465; http://dx.plos.org/10.1371/journal.pone.0036465.g002; http://dx.plos.org/10.1371/journal.pone.0036465.t002
Public Library of Science (PLoS)
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know